Ohio Public Employees Retirement System (OPERS)’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,658
Closed -$126K 2381
2025
Q4
$126K Buy
+1,658
New +$120K ﹤0.01% 1752
2025
Q1
Sell
-5,542
Closed -$250K 2399
2024
Q4
$250K Sell
5,542
-17,657
-76% -$756K ﹤0.01% 1630
2024
Q3
$861K Sell
23,199
-3,780
-14% -$127K ﹤0.01% 1278
2024
Q2
$825K Sell
26,979
-1,632
-6% -$52.9K ﹤0.01% 1175
2024
Q1
$832K Sell
28,611
-1,235
-4% -$34.6K ﹤0.01% 1163
2023
Q4
$823K Buy
29,846
+1,500
+5% +$34.3K ﹤0.01% 1183
2023
Q3
$635K Buy
28,346
+5,200
+22% +$193K ﹤0.01% 1207
2023
Q2
$941K Buy
23,146
+5,873
+34% +$287K ﹤0.01% 1173
2023
Q1
$837K Sell
17,273
-20,719
-55% -$947K ﹤0.01% 1187
2022
Q4
$1.45M Buy
+37,992
New +$1.58M 0.01% 1089
2017
Q4
Sell
-11,582
Closed -$232K 1860
2017
Q3
$232K Buy
11,582
+3,835
+50% +$75.1K ﹤0.01% 1490
2017
Q2
$142K Buy
+7,747
New +$104K ﹤0.01% 1565

Other funds holding PTCT

Ohio Public Employees Retirement System (OPERS)'s PTCT Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 1,658 shares — an estimated $126K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in PTCT in Q2 2017 and held it in 12 quarters. The position peaked at $1.45M in Q4 2022. 352 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 1,658 PTC Therapeutics shares in Q1 2026, an estimated $126K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in PTC Therapeutics in Q2 2017 and held it in 12 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s PTC Therapeutics position peaked at $1.45M in Q4 2022.
  • 352 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.